• PL-PULSEX-P30
1 1

Dual growth-hormone-axis research peptide blend

PULSE-X CJC-1295 + Ipamorelin Research Pen

PULSE-X CJC-1295 + Ipamorelin Research Pen

CJC-1295 (No DAC / Modified GRF 1-29) + Ipamorelin

Dhs. 849.00 AED
Dhs. 849.00 AED
Sale Sold out
Strength

Disclaimer

For research purposes only. Peptiva Labs products are supplied exclusively for scientific laboratory research and analytical purposes. They are not intended for human or animal use, and must not be misused in any way that contravenes applicable laws.

  • Research Grade Peptides – batch documentation available where supplied
  • Supplied in sterile, flip-top vials designed for laboratory use
  • Handled as a research-use laboratory supply only

All Peptiva Labs peptides are supplied strictly for research and laboratory use only. Each vial contains sterile, lyophilised powder that has been finely milled and sieved to ensure consistency. The stated weight refers to the content of a single vial. Reconstitution requires bacteriostatic water containing 0.9% benzyl alcohol, or a suitable equivalent. We do not offer any advice or recommendations regarding dosage, administration, or use in humans or animals.

PULSE-X combines a short-acting GHRH analog with a ghrelin-receptor agonist in a 3 mL pre-filled research pen for laboratory investigation of complementary pituitary growth-hormone signaling pathways.

Specifications

Active material
CJC-1295 (No DAC / Modified GRF 1-29) + Ipamorelin
Declared presentation
15 mg CJC-1295 (No DAC) + 15 mg Ipamorelin; 30 mg total per pen
Container
3 mL nominal cartridge; one pre-filled, pre-mixed blend pen
Nominal concentration
10 mg/mL total nominal; 5 mg/mL of each component
CAS number(s)
No single blend CAS. CJC-1295 No DAC: 863288-34-0. Ipamorelin: 170851-70-4.
Molecular formula
CJC-1295 No DAC C152H252N44O42. Ipamorelin C38H49N9O5.
Molecular weight
CJC-1295 No DAC approximately 3367.9 g/mol. Ipamorelin approximately 711.85 g/mol.

What this material is studied for
  • GHRH receptor and ghrelin receptor (GHS-R1a) signaling studies.
  • Growth-hormone pulse and downstream IGF-axis biomarker research.
  • Comparative single-agent versus combination studies in validated models.

Scientific context

CJC-1295 without DAC activates the GHRH receptor, while ipamorelin activates the ghrelin receptor. Both pathways can stimulate pituitary growth-hormone signaling, but controlled evidence for this exact combination remains limited.

Storage and handling

Store the pre-mixed research pen refrigerated at 2–8 °C (36–46 °F). Keep it protected from direct light and do not freeze. The product label, assigned expiry date and formulation-specific stability data take precedence.

View full details